Faeth Therapeutics

Forecast & Rating16 analysts currently cover Faeth Therapeutics, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $55.38, about 224.3% upside from the current price of $17.08. Price targets range from $40.00 to $70.00 — a wide spread, showing clear disagreement over just how much Faeth Therapeutics can rise. For you, this means most professionals who study Faeth Therapeutics closely still see room for the stock to rise. Data as of Oct 23, 2026; for reference only and not investment advice.